Case Study: a leading biotech company accelerates clinical genomics insights with Provectus

Accelerating Treatment Decisions and Drug Discovery on a Modern Clinical Genomics Database

The leading biotech company, a global leader in advanced cancer diagnostics, sought to streamline genomic data annotation and democratize its internal clinico-genomic data for R&D. Their challenge was to create a solution that enabled faster at-scale utilization of this data to improve testing capabilities and empower their teams and biopharma partners. They engaged Provectus to develop a modern clinical genomics data platform.

Provectus delivered a highly scalable, cost-effective platform on AWS, which involved migrating data, unifying diverse datasets, and developing new analytical products. This solution dramatically accelerated the company's genomic data annotation throughput and reduced the associated unit cost. The platform's user-friendly interface allows researchers to analyze data in seconds instead of hours and has enabled the creation of a unique early-stage cancer patient database, accelerating drug discovery and personalized treatment.